C M Bidwell & Associates LTD Perkinelmer Inc Transaction History

C M Bidwell & Associates LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$118.07 - $160.96 $472 - $643	4 Added 0.23%	1,754 $211,000
Q2 2022 Aug 12, 2022	SELL	$134.91 - $172.49 $6,070 - $7,762	-45 Reduced 2.51%	1,750 $249,000
Q1 2022 Apr 29, 2022	SELL	$162.31 - $192.2 $973 - $1,153	-6 Reduced 0.33%	1,795 $313,000
Q4 2021 Feb 11, 2022	SELL	$166.66 - $201.06 $18,665 - $22,518	-112 Reduced 5.85%	1,801 $362,000
Q3 2021 Nov 12, 2021	SELL	$151.98 - $190.5 $10,182 - $12,763	-67 Reduced 3.38%	1,913 $332,000
Q2 2021 Aug 13, 2021	BUY	$127.81 - $155.84 $19,171 - $23,376	150 Added 8.2%	1,980 $306,000
Q1 2021 May 14, 2021	BUY	$120.35 - $160.53 $220,240 - $293,769	1,830 New	1,830 $235,000

576

108M

57.1K

23.1K

Ticker PKI
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 126,224,000
Market Cap $15.3B
Description
PerkinElmer, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment offers a suite of solutions, including reagents, informatics, and detectio...

Get notified when there are updates to the investment portfolio of C M Bidwell & Associates LTD, based on Form 13F filings with the SEC.

Stay updated on C M Bidwell & Associates LTD with notifications on news.